QURE vs SCL
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
QURE · uniQure NV$21.70 ▲ 3.28%
SCL · Stepan$66.94 ▼ 1.34%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- QURE -17.0%
- SCL +56.9%
Head to head
| Metric | QURE | SCL |
|---|---|---|
| Price | $21.70 | $66.94 |
| Change today | ▲ 3.28% | ▼ 1.34% |
| Market cap | $1.52B | $1.52B |
| Return, 3 months | -52.9% | +3.9% |
| Return, year to date | -9.3% | +44.4% |
| Return, 1 year | -21.9% | +59.3% |
| P/E (TTM) | – | 352.3 |
| P/B | 5.2 | 1.2 |
| P/E percentile vs own 5y | 28th | 100th |
| Dividend yield | – | 2.36% |
| Revenue growth (YoY, latest qtr) | +11.0% | +17.3% |
| Net profit growth (YoY) | -114.9% | +64.3% |
| Gross margin | 92.5% | 12.0% |
| Operating margin | -1,020.8% | 3.6% |
| Net margin | -1,350.7% | 0.2% |
| Return on equity | -157.6% | 0.4% |
| Analyst target vs. price | +138.1% | +27.0% |
| Analyst buy share | 78% | 100% |
| RSI (14) | 36 | 55 |
| 30-day volatility | 149.0% | 28.1% |
| Max drawdown, 1 year | -87.2% | -32.8% |
| Trend read | Leaning bearish | Strong uptrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- QURE is the largest of the group by market value.
- SCL has returned the most over the past year.
- SCL is growing revenue fastest.
- SCL keeps the most profit per dollar of sales.
- SCL has been the calmest stock over the last 30 days.